Thomas Hong, MD
Clinical Cardiac Electrophysiology · Houston, TXNPI 1235121294
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.3%), consulting fees and other — rather than concentrated in one kind of arrangement. Abbott accounts for 67.8% of it on its own, with 30 other manufacturers making up the rest. Reporting peaked in 2020 at $12,035 and has fallen 76.3% since, to $2,850 in 2025.
Across 1,865 payments — averaging $30.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$39K
- Angiodynamics, Inc.$7K
- Biosense Webster, Inc.$6K
- Boston Scientific$2K
- Biotronik Inc.$826
- Medtronic$791
- plus $2K from 25 others
Across 15 payments — averaging $1335.30 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$20K
What the payments were for
- Consulting fees$21,35337%
- Travel & lodging$7951%
- Food & beverage$28,50349%
- Education$1,5433%
- Other$5,58310%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 1,222 | $39,176 |
| Angiodynamics, Inc. | 2 | $6,883 |
| Biosense Webster, Inc. | 430 | $6,497 |
| Boston Scientific | 68 | $1,557 |
| Biotronik Inc. | 16 | $826 |
| Medtronic(2 entities) | 49 | $791 |
| Elutia, Inc. | 7 | $289 |
| Pfizer | 20 | $260 |
| Stimwave Technologies Incorporated | 1 | $180 |
| Cardiva Medical, Inc. | 5 | $156 |
| E.r. Squibb & Sons, L.L.C. | 7 | $139 |
| Acutus Medical, Inc. | 1 | $135 |
| Johnson & Johnson | 7 | $117 |
| Tactile Systems Technology Inc | 5 | $103 |
| Bardy Diagnostics, Inc. | 1 | $83 |
| Stryker | 2 | $73 |
| G Medical Diagnostic Services, Inc. | 1 | $63 |
| Sanofi-aventis U.S. LLC | 4 | $63 |
| Impulse Dynamics (USA) Inc. | 3 | $61 |
| Biotronik NRO, Inc. | 1 | $57 |
| Kestra Medical Technology Services, Inc. | 2 | $45 |
| BD | 1 | $44 |
| Bridgebio Pharma, Inc. | 1 | $30 |
| MML US, Inc. | 2 | $27 |
| Altathera Pharmaceuticals LLC | 1 | $23 |
| Alnylam Pharmaceuticals Inc. | 1 | $21 |
| Atricure, Inc. | 1 | $19 |
| Irhythm Technologies, Inc. | 1 | $17 |
| Avinger Inc. | 1 | $16 |
| GE HealthCare | 1 | $15 |
| Heartflow, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ensite Cardiac Mapping System$13,353
- Auryon Laser System 100-120 Vac$6,883
- TactiCath Quartz CFA Catheter$2,600
- ALLURE$2,350
- EnSite Precision Cardiac Mapping System$1,856
- ACCENT$1,300
- AMPLATZER AMULET$707
- Acticor$301
- Solia$301
- Rivacor$301
- Edora$301
- BioMonitor$301
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$266
- AVEIR$265
- SPECTRA WAVEWRITER$252
- Carto 3$197
- Quadra Assura CRT Defibrillator$180
- Fortify Assura$178
- ENSITE PRECISION$160
- WaveWriter Alpha Prime 16$153
How this compares
$57,777 in reported general payments places this provider in the 65th percentile of 233 clinical cardiac electrophysiology providers in Texas.
See all clinical cardiac electrophysiology providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 295 | $261,529 |
| MultaqDronedarone Hcl | 58 | $49,242 |
| XareltoRivaroxaban | 41 | $46,226 |
| Dofetilide | 38 | $7,979 |
| Flecainide Acetate | 145 | $4,450 |
| Propafenone Hcl ErPropafenone Hcl | 27 | $3,846 |
| Metoprolol Succinate | 183 | $3,475 |
| SotalolSotalol Hcl | 84 | $2,775 |
| Mexiletine Hcl | 16 | $2,510 |
| Amiodarone Hcl | 107 | $1,997 |
| Digoxin | 32 | $577 |
| ClopidogrelClopidogrel Bisulfate | 27 | $357 |
| Metoprolol Tartrate | 47 | $343 |
| Minocycline Hcl | 78 | $321 |
| Atorvastatin Calcium | 17 | $183 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $260 | $261,529295 claims |
| Sanofi-aventis U.S. LLCMultaq | $63 | $49,24258 claims |
| Johnson & JohnsonXarelto | $117 | $46,22641 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 233 clinical cardiac electrophysiology providers in Texas.
Other clinical cardiac electrophysiology in Houston
- Miguel ValderrabanoHouston$461K
- Mehdi RazaviHouston$358K
- Ilyas ColombowalaHouston$204K
- Ramesh HariharanHouston$165K
- Nadim NasirHouston$162K
- John SegerHouston$147K
- Alexander DrtilHouston$126K
- Hamid Afshar-KharaghanHouston$112K
- David BurklandHouston$101K
- Jie ChengHouston$82K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.